Vedolizumab
…m diagnosis. 21/23 (91%) received antiTNF prior to switching to Vedolizumab. 2/23(8.7%) had received Ustekinumab. 19/23 (82.6%) were on Aza…
1articles mentioning drugs
2drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: vedolizumab-drug-levels ×
vedolizumab-drug-levels
This drug is selected. Its supporting articles are shown below.